RT info:eu-repo/semantics/article
T1 Single-dose cholera vaccine in response to an outbreak in Zambia
A1 Ferreras Barrera, Eva
A1 Chizema-Kawesha, Elizabeth
A1 Blake, Alexandre
A1 Chewe, Orbrie
A1 Mwaba, John
A1 Zulu, Gideon
A1 Poncin, Marc
A1 Rakesh, Ankur
A1 Page, Anne-Laure
A1 Stoitsova, Savina
A1 Voute, Caroline
A1 Uzzeni, Florent
A1 Robert, Hugues
A1 Serafini, Micaela
A1 Matapo, Belem
A1 Eiros Bouza, José María
A1 Quilici, Marie-Laure
A1 Pezzoli, Lorenzo
A1 Azman, Andrew S.
A1 Cohuet, Sandra
A1 Ciglenecki, Iza
A1 Malama, Kennedy
A1 Luquero, Francisco J.
K1 Vacuna
K1 Cólera
K1 32 Ciencias Médicas
AB Killed oral cholera vaccines (OCVs) are part of the standard response package to a cholera outbreak, although the two-dose regimen of vaccines that has been prequalified by the World Health Organization (WHO) poses challenges to timely and efficient reactive vaccination campaigns.1 Recent data suggest that the first dose alone provides short-term protection, similar to that of two doses, which may largely dictate the effect of OCVs during epidemics
PB Massachusetts Medical Society
SN 0028-4793
YR 2018
FD 2018
LK http://uvadoc.uva.es/handle/10324/44691
UL http://uvadoc.uva.es/handle/10324/44691
LA eng
NO New England Journal of Medicine, 2018, vol. 378, n.6, p. 577-579
NO Producción Científica
DS UVaDOC
RD 24-dic-2024